Fundraising Fox

Cingulate Therapeutics

Morristown, US · Delaware LLC

Biotech

Founders & leadership

SJ
Shane j SchafferFounder
LG
Louis George Van HornExecutive
RR
Raul R SilvaExecutive
LA
Laurie A MyersExecutive
MN
Matthew N BramsExecutive
CS
Craig Steven GilgallonExecutive

Board

PJ
Patrick J GallagherBoard director
AB
Arthur B StraughnBoard director

Reported raises · per SEC filings

Form D private placements

$33M disclosed across 2 rounds · 2013

▶$26.2MraisedJun 2020 · 203 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew N BramsExecutive Officer, Director
  • Jeff ConroyDirector
  • Louis George Van HornExecutive Officer
  • Craig Steven GilgallonExecutive Officer
  • Laurie A MyersExecutive Officer
  • Raul R SilvaExecutive Officer
  • Patrick J GallagherDirector
  • Jeff HargrovesDirector
  • Arthur B StraughnDirector
  • Shane J SchafferExecutive Officer, Director
  • Peter WerthDirector
Amount sold
$26.2M
Minimum investment
$100K
Proceeds to insiders
$1.3M
First sale
Nov 2013
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$6.8MraisedJan 2018 · 116 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Louis George Van HornExecutive Officer
  • Raul R SilvaExecutive Officer
  • Laurie A MyersExecutive Officer, Director
  • Matthew N BramsExecutive Officer, Director
  • Shane j SchafferExecutive Officer, Director
  • Patrick J GallagherDirector
  • Craig Steven GilgallonExecutive Officer
  • Arthur B StraughnDirector
Amount sold
$6.8M
Minimum investment
$5K
Proceeds to insiders
$100K
First sale
Nov 2013
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Cingulate Therapeutics?
Cingulate Therapeutics was founded by Shane j Schaffer.
How much funding has Cingulate Therapeutics raised?
Cingulate Therapeutics has disclosed $33M raised across 2 rounds.
Where is Cingulate Therapeutics headquartered?
Cingulate Therapeutics is headquartered in Morristown, US.